Lipase inhibitors
US8668921B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2005 |
| Grant date | Mar 11, 2014 |
| Priority date | — |
| Expiry date | Jan 11, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23V2002/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of assamicains represented by the formula:wherein G represents a galloyl group;theasinensins represented by the formula:wherein R1 represents G or H, and R2 represents G; andtheaflavins represented by the formula:wherein R1 and R2 independently represent G or H; as well as foods and beverages and medicines containing said lipase inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.